clinical research solutions

A global team of trusted experts for multi-phase clinical development.

Clinical research solutions flywheel heading logo.
Clinical research solutions flywheel heading mobile logo.
Colorized half circle.
clinical-research-solutions-consultant

Leading Clinical Research Organization

Our team of clinical research experts brings depth and breadth of experience across all phases of clinical trials, applying proven techniques to provide innovative solutions. Regardless of where you are in the product lifecycle or what your clinical trial–related needs are, we offer clinical research solutions to efficiently bring your product to market. With decades of industry experience, our team of clinical research experts is current with the latest industry intelligence and ever-evolving regulations, making ProPharma the partner of choice when outsourcing your clinical trials.

All Clinical Research Solutions:

Our clinical research experts offer solutions to bring your product to market, regardless of where you are in your product’s lifecycle.

 

Full-Service CRO

The path to project success begins with choosing the right model and methodology to anticipate and manage the challenges that could arise during the lifecycle of a clinical trial. In response to more stringent regulations, globalization, and ever-changing technologies, ProPharma can build and tailor the optimal operational model to support consistent quality delivery and maximize participant recruitment and retention while expanding access to diverse populations. We will work with you to develop strategic, flexible approaches that leverage technology, clinical informatics, and our global reach to maximize data‑driven decision making that drives safety, quality, and efficiency.

Explore Full-Service CRO

Clinical Operations Services

Clinical operations play a pivotal role in the successful execution of clinical research, encompassing the design, implementation, and management of Phase I to IV trials.

With the increasing complexity of clinical trials, driven by heightened regulatory guidelines, the pressure on clinical operations teams has intensified. While some organizations allocate considerable time and resources to this aspect, others opt to outsource their clinical trials to Contract Research Organizations (CROs) specializing in the specific field of research. These CROs offer comprehensive services, ensuring end-to-end support for the seamless execution of trials.

Our dedicated clinical operations team collaborates with you to optimize the design of your clinical trials, implement patient-centric approaches, and provide guidance throughout the entire clinical development lifecycle. Discover how our experts can assist you in the multi-phase development of your clinical operations.

Explore Clinical Operations

Two women technicians using a laptop in a laboratory.

Global Clinical Trial Management Teams

Global footprint, local expertise: we provide the flexibility you need in a rapidly evolving environment. Our experienced teams offer the footprint to meet your local clinical trial needs, with the confidence and agility to globalize when you are ready. Our global governance structure streamlines the complexity of multi-region studies.

Data Safety Monitoring Board

Data Safety Monitoring Board (DSMB) services provide you with improved workflows, compliance, and communication to ensure the safety and integrity of your clinical study data.

PhoPharma’s team of medical consultants provide the option of safety data review (i.e., individual case safety reports and/or aggregate summaries of data) by a physician with experience in pharmacovigilance. The review and consultation include an assessment of the data and its significance to the conduct of the study. Our team then provides a recommendation for any actions to be taken, including reporting of aggregate data to the FDA as an IND Safety Report, requesting review by the DSMB, and/or changes to the Investigator's Brochure, Informed Consent Form, or study protocol.

ProPharma's DSMB, medical monitoring, and physician teams support a wide variety of therapeutic areas and will meet your requirements and keep your study moving forward by providing any or all of the following services:

  • DSMB program support
  • Blinded and unblinded DSMB meeting support
  • Eligibility requirements review for inclusion/exclusion criteria issues
  • Protocol review for exemptions and deviations
  • Medical crisis impact review involving a study patient
  • Biostatistician review
  • Laboratory findings review
  • Reporting a serious adverse event (SAE)
  • Causality assessment discussions
  • Clinical Trial Emergency Unblinding Services

Medical Monitoring Services

At ProPharma, our medical monitoring consultants will work with you to ensure safety and compliance throughout your clinical trials, from pre-trial planning through end-of-trial review.

Our team of physicians can evaluate your medical monitoring system to ensure there are no pharmacovigilance medical monitoring bandwidth issues, and partner with you to ensure you have the right resources to keep your clinical trials on schedule.

We will help you meet requirements to maintain quality and compliance throughout your clinical trials. Our medical monitors have vast knowledge in a wide variety of therapeutic areas and partner with you to address all your needs, including:

  • Inclusion/exclusion criteria issues
  • Protocol exemptions and deviations
  • Medical crisis monitoring for cases involving a study patient
  • Medication issues
  • Laboratory findings
  • SAE reporting
  • Causality assessment discussions

Contact us to learn more about our medical monitoring services and how we can provide expert guidance for your upcoming clinical trials.

Talk to an Expert

Clinical Trials for Pharmaceuticals, Biologics, Medical Devices, and Diagnostics

With dedicated pharmaceutical, medical device, and diagnostics teams, ProPharma supports clinical trials in the most cutting-edge technologies, maintaining expertise in novel uses of less novel therapeutics, and repurposing products. We have internal SMEs including a Biologics Center of Excellence and create solutions to complex challenges.

Expertise Across All Study Phases and Therapeutic Areas / Specialties

Our teams work together to take you all the way through the development lifespan, from early pilot studies dose-ranging studies through pivotal registration studies. We focus on the patients, providing consistent delivery of the quality data you need.

Deep Functional Expertise

ProPharma’s Medical Writing teams create best-in-class quality documents to support all elements of your clinical trial needs, from protocol and consent forms, Investigator’s Brochures, clinical study reports, patient narratives, and CTD Module documents, to registering and disclosing clinical trial information on public registries and redacting documents to meet commercial transparency obligations while protecting patient and company confidentiality.

Our world-class Biostatistics and Data Management teams and programmers are adept at creating and managing quality design, build, and outputs. They will partner with you to ensure you achieve the most robust and successful outcomes, incorporating unique and adaptive designs where best suited.

Global pharmacovigilance specialists and medical monitors are here to support the safe implementation of your studies, and provide expert guidance, reporting, and DSMB management. We have a range of disease and therapy area experts to ensure you have the best, contemporary advice.

Explore Full-Service CRO

Functional Service Provider (FSP)

Clinical trials can be a costly drain on time and resources. Working with a quality FSP allows you to save on cost when outsourcing specific clinical services. This enables the project to reach completion faster while improving the overall quality of the work and driving efficiencies. As part of our FSP model, we provide functional expertise, resource management, and innovative solutions that are customized to meet the specific needs of our clients.

ProPharma offers a range of FSP models to fit all requirements, providing specific therapeutic area expertise, operational expertise, and integrated processes and systems, to ensure we map the right outsourcing approach to fit your project. We help our clients develop solutions that span clinical operations and clinical data sciences, as well as safety, nonclinical, and regulatory writing.

ProPharma provides all levels of support ranging from deploying a small group of experts within a function to supplementing an entire department of full-time equivalent staff. Our team of experts works as an extension of your team, bringing you immediate scalable resources who will align with your processes and environment. With our collaborative approach, we can provide strategic solutions that are built on a foundation of strong partnerships.

Explore FSP

exceptional-quality

Exceptional Quality

By monitoring key metrics, checking for variations, evaluating enforcement trends, and investing in industry-leading expertise, we become your partner with measurable results. When you work with us, you get a high-caliber team that analyzes your KPIs to optimize your existing operational environment and develops tailor-made solutions that fill the gaps to create exceptional results.

Speed to Global Scale

Our industry-leading experts span the globe to offer you a scalable network of professionals to execute your most complex and resource-dependent initiatives. ProPharma provides a flexible, dedicated, and global resource team that is scaled to accommodate your individual clinical trial needs.

Therapeutic Expertise

Our team consists of SMEs with varied backgrounds across the pharmaceutical, biotechnology, medical device, and diagnostic industries. With our deep-rooted expertise across countless therapeutic areas, we can anticipate obstacles and develop a strategy that fits our clients’ unique needs. Having a top-tier team of professionals allows our FSP infrastructure to move resources internally across clinical programs.

100% Dedicated Teams

We don’t just offer solutions; we tailor them to your needs with experts who are experienced across all phases of clinical development. At ProPharma, we know that a successful compound starts with the right team, and we’ll build it with you. Our FSP model is a Win-Win Functional solution because it fosters a partnership that brings together shared expertise & industry experience.

Time and Cost Efficiencies

The FSP model offers significant reduction in costs with greater potential to drive operational efficiencies over time. We enable companies to grow in infrastructure without the headcount burden & risks associated with HR costs & processes. Let ProPharma manage the administrative burden, so you can concentrate on the core tasks of the clinical trial, ensuring business continuity and driving efficiencies.

Explore FSP

Decentralized Clinical Trials

Decentralized Clinical Trials (DCTs) are studies that are designed for study visits, procedures, and data collection to occur outside of the traditional site setting. DCTs revolve around the concept of patient centricity, with the goal of making participation easier and more convenient for the patient, ultimately creating a larger, more diverse population to test your drug or device while ensuring patient comfort and safety. The increased flexibility of DCTs expands the geographical reach, improves recruitment and retention, and enhances the patient experience while providing Sponsors with reliable data.

We support DCTs by providing the opportunity for study visits to take place in a location convenient to the patient, such as their home or office, supported by our team of employee GoClinical Clinicians who are trained in GCP and protocol-specific procedures. 

Home Visits

It can be overwhelming to determine how to deploy a decentralized approach, so incorporating home visits into your protocol is often a great place to start. ProPharma can support home visits as part of a hybrid or completely virtual trial design. Home visits allow for greater flexibility in your study design and reduce the burden of participation on the patient by designing processes that fit into the patient’s life, rather than asking the patient to fit their life into the trial. Allowing simple procedures to be performed in the patient’s home, also reduces the burden on the site by allowing site staff to focus on recruiting and enrolling patients and more complex procedures.

Employee Nursing Staff

ProPharma directly employs all GoClinical Clinicians (GCCs) to support your patients. Once hired, all GCCs are overseen by our Director of DCT Nursing and receive extensive training in GCP, IATA (Dangerous Goods), and protocol-specific procedures. This allows us to have direct oversight of all visits and ensures those visits are performed by known, high-quality clinicians with strong clinical skills and trial experience. GCCs are selected based on study requirements and range from phlebotomists, LPNs, and RNs. We are easily able to add GCCs based on location by leveraging extensive Global Talent Acquisition team and sister staffing companies, with over 25,000 qualified providers currently in our global database. Our approach reduces sponsor costs, removes unnecessary layers of vendor administration, and alleviates the challenges of finding providers with short notice through local home health agencies, significantly reducing the risk of missed visits.   

 

employee-nursing-staff

 

Proprietary eSource Technology

GoClinical, our proprietary, 21 CFR Part 11 and GDPR compliant eSource platform allows for the collection of source data from home visits and electronically sends data for entry into the EDC. All source forms are designed per study to mirror the CRF and act as a guide for our GCCs performing home visits. This approach to source collection significantly reduces source turnaround times, reduces documentation errors, and improves PI oversight.

Experience and Global Reach

ProPharma has invested in hiring the best leaders within the Decentralized Clinical Trial (DCT) space to build out the most efficient operational strategy based on lessons learned from several years of past experience. As the decentralized approach grows in the clinical research space, it is becoming even more important for Sponsors to have a reliable partner that can assist in designing trials with decentralized approaches in mind. Our DCT leadership team has over 10 years of experience in the DCT space and can help your team design and implement the right DCT solutions for your trial. Whether you’re interested in hybrid or completely virtual clinical trials, our team of experts can help.

ProPharma has 27 offices worldwide spanning 6 continents, providing a truly global footprint to support your decentralized clinical trials. ProPharma has 20 years of experience supporting Sponsors from early development through commercialization, which allows for expert insight at any phase or function of your study and a streamlined approach from a single provider.

decentralized-clinical-trial-visit-procedures

Decentralized Clinical Trial Visit Procedures

Our decentralized visits include critical procedures for your clinical trial’s success. Let our team of experts review your protocol or draft synopsis and consult with your team on what visits or studies could benefit from a DCT model. Our procedural capabilities are as follows:

 

 

  • Vital Signs and Associated Variables
    • Temperature
    • Respirations
    • Blood Pressure
    • Pulse/Pulse Oximetry
    • Weight/Height/BMI
  • Lab Sample Collection and Processing
    • Blood/Plasma
    • Urine
    • Saliva/Sputum
    • Stool
    • Finger Sticks
  • IP Logistics
  • Targeted Clinical Assessments
  • IP Administration
    • Infusion
    • Injection
    • Oral
    • Topical
  • Telehealth Support
  • Patient-Reported Outcomes and Scales
  • Patient Training
    • IP Administration
    • Diary Completion
    • Device or Wearables
  • Other Safety Assessments
    • Changes in Health Status or Concomitant Medications
    • ECG Collection

Explore Decentralized Clinical Trials

Embedded Solutions

Our team of project leaders and clinical subject matter practitioners can support you in your journey to successfully deliver projects, achieve critical outcomes, and realize or improve efficiencies. Whether you are looking for an expert to provide advisory services or several cross-disciplinary personnel our solutions-focused approach will add value to your organization.

Specialized Project-Based Services

Our team of qualified consultants apply proven and proprietary project management methodologies to help you successfully develop and launch products to market safely and quickly. By focusing on your desired outcomes, we take time to thoroughly plan the solution. We have done these projects before and understand the functional dependencies that can impact the plans and know what works.

In-Depth Expertise

Our team of clinical experts bring leadership to your projects to help you successfully complete your important, complex projects regardless of where your team is in the clinical development process. We help you get to decisions quickly and achieve outcomes.

Explore Embedded Solutions

Global Medical Writing Transparency

ProPharma strategically partners with clients to provide individualized, single-source, scalable medical writing solutions across the following areas:

  • Medical Writing – Clinical, Nonclinical, Device, Diagnostics, and Publications
  • Quality Control Review and Editing
  • Clinical Trials Disclosure – Document Redaction/Anonymization, Clinical Trial Registry Authoring, Plain Language Authoring, and Management Consultation
  • Project Support – Project Management, Document Publishing, Submission Management, SOP Development/Template Creation

Our global team of medical writers and reviewers have deep domain expertise and autonomously drive projects to completion, collaborating with cross-functional teams to coordinate all aspects of input, production, and review of every document with a laser focus on quality.  Whether you need to outsource all medical writing across several clinical trials or a portfolio of products, or you need project-based support for individual medical writing deliverables, our expertise and experience can be leveraged to build a customized solution that achieves all your project goals. 

Explore Global Medical Writing Transparency

Clinical Research Solutions Experts

  • Marcy Komocsar Bio Photo

    Marcy Komocsar

    Senior Vice President, Clinicial Research Solutions

  • Alena Hammond Bio Photo

    Alena Hammond

    Global Head, Clinical Operations

  • Marija Buchholz Bio Photo

    Marija Buchholz

    Senior Vice President, Global Clinical Operations

  • Helen Hall Bio Photo

    Helen Hall

    Global Head, Clinical Data Sciences

  • Shelby Stillwagon Bio Photo

    Shelby Stillwagon

    Vice President, Decentralized Clinical Trials

    View Bio

  • Kevin Wysocki Bio Photo

    Kevin Wysocki

    President, Clinical Research Solutions

Shelby started her career in academic research, then moved to the clinical site environment, working in oncology, and has spent the past 11 years focused on supporting and operationalizing Decentralized Clinical Trials. Since 2013, Shelby has worked with numerous sponsors across hundreds of clinical trials, where she has provided expert guidance on decentralized visit design and logistics. She has held multiple oversight roles, supporting global teams across a wide variety of therapeutic areas including rare disease, pediatrics, oncology, neurology, and infectious diseases. Her expertise lies in collaborating with involved stakeholders to build and maintain study-specific, quality-focused processes that support complex decentralized clinical trials.

News & Insights

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

December 23, 2024

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

Discover strategies for establishing a medical information function in JAPAC, overcoming diverse regulations, data privacy laws, and cultural nuances.

WHO Issues Guidance on Antibiotic Pollution Control

December 23, 2024

WHO Issues Guidance on Antibiotic Pollution Control

WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

December 18, 2024

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Award Arrow Next Award Arrow
Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

December 23, 2024

Excelling in the JAPAC Medical Information Landscape: Key Considerations and Insights

Discover strategies for establishing a medical information function in JAPAC, overcoming diverse regulations, data privacy laws, and cultural nuances.

WHO Issues Guidance on Antibiotic Pollution Control

December 23, 2024

WHO Issues Guidance on Antibiotic Pollution Control

WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

December 18, 2024

Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding

Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow
Gradient Image

Complex Needs Require Custom Solutions

ProPharma builds solutions at the intersection of innovation and flexibility. We’re here to offer a custom alternative that fits your unique needs. Standout solutions scaled to your size.